Small study: OTC antihistamine shows potential as a remyelinating agent in MS

VANCOUVER – Clemastine fumarate (Tavist) reduced delay in visual evoked potentials by 1.9 ms per eye, with a trend toward improved low contrast visual acuity, in a small randomized,...

Source: Clinical Neurology News - April 20, 2016 Category: Neurology Source Type: news